🔗 Share this article

An underground market for unapproved slimming drugs is being driven by TikTok fitness influencers and vendors on messaging platforms, according to recent findings.

Investigational Drug Acquiring Popularity Via Social Media

Retatrutide, which is still in clinical trials, is being promoted by online personalities for its supposed weight-reducing effects. Followers are urged to contact these profiles privately for supplier links, while also receiving discount codes.

Thriving Commerce on Social Networks

Separately, a robust trade exists on messaging services, where communities with thousands of members share “before and after” images, administration instructions and assertions of next-day British shipping. Vendors promote the substance there before directing buyers to WhatsApp for transactions.

Understanding The Experimental Drug

This medication is an investigational injection created by American pharmaceutical company Eli Lilly. The treatment targets three gut hormones – GLP-1, glucose-dependent insulinotropic polypeptide and glucagon. Early trials suggest it could help individuals lose up to a quarter of their total weight. Referred to as the “triple G”, the drug is being promoted online as the next Ozempic.

Medical Professionals Voice Concerns

Nevertheless, doctors and pharmacists have warned that the distribution of what is still an unlicensed medication in the United Kingdom is a cause for concern and could result in individuals administering products of unknown origin.

Some experts said the popularity for retatrutide could be connected to the rising cost of licensed slimming treatments such as Mounjaro.

Regulatory Status and Implementation

Selling retatrutide on social media or Telegram is prohibited in the United Kingdom, as it is an unlicensed drug that must not be marketed or supplied for personal consumption under the Human Medicines Regulations 2012.

Some influencers try to sidestep the rules by calling to the drug as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a restricted drug, but advertising and supply can still violate medicines, marketing, and consumer laws, potentially leading to fines, legal action or prison.

Service Reaction and Material Elimination

Based on the social media company, the platform has removed problematic content and banned related hashtags and query recommendations. The organization stated it was committed to keeping the platform secure and investing in strengthening compliance measures.

Digital Marketplace Operations

Investigations also found groups with up to 9,000 participants selling the experimental drug using Telegram's built-in discovery tool, which functions like a public directory. Entering “retatrutide” instantly brings up channels with thousands of users, populated with photos of slimming results, glowing testimonials and step-by-step instructions for preparing or injecting at home.

After minutes of entering one group, a seller shared WhatsApp details, where the majority of purchases occur. The vendor sent an instruction manual and promised delivery within two days. When asked whether the substance was genuine, one vendor said: “You can’t be sure.” Another provided a photo of a supposed laboratory certificate. Not one asked about body mass, medical conditions or previous experience.

Item Details and Pricing

Within these communities, posts show dark colored parcels with postal service stickers, stating to contain new batches. One message stated: “It took eight of us to load them this morning.”

Customers can choose between powder vials, mixed at home with sterile water, or pre-filled injectors usually priced at 160 pounds for 20mg. When asked how long a injector should be used, vendors give contradictory answers ranging from a few weeks to “depends on your body”.

Platform Moderation and Security Measures

A spokesperson for the messaging service stated it regularly moderated dangerous content on its service including material that promoted the “misuse of controlled medications”. The organization added that it removed “millions of pieces of harmful content each day”.

Medical Expert Cautions

“Individuals are injecting materials they cannot confirm. Although the science behind this drug is valid, these digital products may not include what they advertise,” said a pharmacy expert, the head of pharmaceutical services at a pharmacy service.

Dr Crystal Wyllie of Asda Online Doctor linked the increase in interest to recent price rises for authorized slimming drugs such as Mounjaro. “With costs rising, patients are turning to social media. But fake treatments are extremely risky. You can’t be certain what’s inside or whether the conditions they were made in was clean,” she explained.

Her staff has already seen patients injured by self-injection from unverified suppliers. “We recognize the disappointment, but purchasing from Telegram or communication platforms is taking chances with your well-being,” said the doctor. “These substances could be impure or improperly measured.”

Manufacturer Position

A spokesperson from Eli Lilly stated the substance was in third stage clinical trials and had not been evaluated or approved by any regulatory agency globally. “Consequently at this time no one can market [it] for personal consumption,” they explained, noting that any item “falsely representing itself as a Lilly experimental substance not yet authorized … may subject users to possibly serious medical dangers”.